Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3

Samuel Sidi, Takaomi Sanda, Richard D. Kennedy, Andreas T. Hagen, Cicely A. Jette, Raymond Hoffmans, Jennifer Pascual, Shintaro Imamura, Shuji Kishi, James F. Amatruda, John P. Kanki, Douglas R. Green, Alan A. D'Andrea, A. Thomas Look

Research output: Contribution to journalArticle

230 Citations (Scopus)

Abstract

Evasion of DNA damage-induced cell death, via mutation of the p53 tumor suppressor or overexpression of prosurvival Bcl-2 family proteins, is a key step toward malignant transformation and therapeutic resistance. We report that depletion or acute inhibition of checkpoint kinase 1 (Chk1) is sufficient to restore γ-radiation-induced apoptosis in p53 mutant zebrafish embryos. Surprisingly, caspase-3 is not activated prior to DNA fragmentation, in contrast to classical intrinsic or extrinsic apoptosis. Rather, an alternative apoptotic program is engaged that cell autonomously requires atm (ataxia telangiectasia mutated), atr (ATM and Rad3-related) and caspase-2, and is not affected by p53 loss or overexpression of bcl-2/xl. Similarly, Chk1 inhibitor-treated human tumor cells hyperactivate ATM, ATR, and caspase-2 after γ-radiation and trigger a caspase-2-dependent apoptotic program that bypasses p53 deficiency and excess Bcl-2. The evolutionarily conserved "Chk1-suppressed" pathway defines a novel apoptotic process, whose responsiveness to Chk1 inhibitors and insensitivity to p53 and BCL2 alterations have important implications for cancer therapy.

Original languageEnglish (US)
Pages (from-to)864-877
Number of pages14
JournalCell
Volume133
Issue number5
DOIs
StatePublished - May 30 2008

Fingerprint

Caspase 2
Caspase 3
DNA Damage
Phosphotransferases
DNA
Automatic teller machines
Tumors
Radiation
Apoptosis
Ataxia Telangiectasia
Neoplasms
Zebrafish
DNA Fragmentation
Cell death
Cell Death
Embryonic Structures
Cells
Mutation
Checkpoint Kinase 1
Therapeutics

Keywords

  • CELLBIO
  • CELLCYCLE
  • SIGNALING

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Sidi, S., Sanda, T., Kennedy, R. D., Hagen, A. T., Jette, C. A., Hoffmans, R., ... Look, A. T. (2008). Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3. Cell, 133(5), 864-877. https://doi.org/10.1016/j.cell.2008.03.037

Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3. / Sidi, Samuel; Sanda, Takaomi; Kennedy, Richard D.; Hagen, Andreas T.; Jette, Cicely A.; Hoffmans, Raymond; Pascual, Jennifer; Imamura, Shintaro; Kishi, Shuji; Amatruda, James F.; Kanki, John P.; Green, Douglas R.; D'Andrea, Alan A.; Look, A. Thomas.

In: Cell, Vol. 133, No. 5, 30.05.2008, p. 864-877.

Research output: Contribution to journalArticle

Sidi, S, Sanda, T, Kennedy, RD, Hagen, AT, Jette, CA, Hoffmans, R, Pascual, J, Imamura, S, Kishi, S, Amatruda, JF, Kanki, JP, Green, DR, D'Andrea, AA & Look, AT 2008, 'Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3', Cell, vol. 133, no. 5, pp. 864-877. https://doi.org/10.1016/j.cell.2008.03.037
Sidi S, Sanda T, Kennedy RD, Hagen AT, Jette CA, Hoffmans R et al. Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3. Cell. 2008 May 30;133(5):864-877. https://doi.org/10.1016/j.cell.2008.03.037
Sidi, Samuel ; Sanda, Takaomi ; Kennedy, Richard D. ; Hagen, Andreas T. ; Jette, Cicely A. ; Hoffmans, Raymond ; Pascual, Jennifer ; Imamura, Shintaro ; Kishi, Shuji ; Amatruda, James F. ; Kanki, John P. ; Green, Douglas R. ; D'Andrea, Alan A. ; Look, A. Thomas. / Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3. In: Cell. 2008 ; Vol. 133, No. 5. pp. 864-877.
@article{efcf1f9606c94f08b42f797c74334bef,
title = "Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3",
abstract = "Evasion of DNA damage-induced cell death, via mutation of the p53 tumor suppressor or overexpression of prosurvival Bcl-2 family proteins, is a key step toward malignant transformation and therapeutic resistance. We report that depletion or acute inhibition of checkpoint kinase 1 (Chk1) is sufficient to restore γ-radiation-induced apoptosis in p53 mutant zebrafish embryos. Surprisingly, caspase-3 is not activated prior to DNA fragmentation, in contrast to classical intrinsic or extrinsic apoptosis. Rather, an alternative apoptotic program is engaged that cell autonomously requires atm (ataxia telangiectasia mutated), atr (ATM and Rad3-related) and caspase-2, and is not affected by p53 loss or overexpression of bcl-2/xl. Similarly, Chk1 inhibitor-treated human tumor cells hyperactivate ATM, ATR, and caspase-2 after γ-radiation and trigger a caspase-2-dependent apoptotic program that bypasses p53 deficiency and excess Bcl-2. The evolutionarily conserved {"}Chk1-suppressed{"} pathway defines a novel apoptotic process, whose responsiveness to Chk1 inhibitors and insensitivity to p53 and BCL2 alterations have important implications for cancer therapy.",
keywords = "CELLBIO, CELLCYCLE, SIGNALING",
author = "Samuel Sidi and Takaomi Sanda and Kennedy, {Richard D.} and Hagen, {Andreas T.} and Jette, {Cicely A.} and Raymond Hoffmans and Jennifer Pascual and Shintaro Imamura and Shuji Kishi and Amatruda, {James F.} and Kanki, {John P.} and Green, {Douglas R.} and D'Andrea, {Alan A.} and Look, {A. Thomas}",
year = "2008",
month = "5",
day = "30",
doi = "10.1016/j.cell.2008.03.037",
language = "English (US)",
volume = "133",
pages = "864--877",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3

AU - Sidi, Samuel

AU - Sanda, Takaomi

AU - Kennedy, Richard D.

AU - Hagen, Andreas T.

AU - Jette, Cicely A.

AU - Hoffmans, Raymond

AU - Pascual, Jennifer

AU - Imamura, Shintaro

AU - Kishi, Shuji

AU - Amatruda, James F.

AU - Kanki, John P.

AU - Green, Douglas R.

AU - D'Andrea, Alan A.

AU - Look, A. Thomas

PY - 2008/5/30

Y1 - 2008/5/30

N2 - Evasion of DNA damage-induced cell death, via mutation of the p53 tumor suppressor or overexpression of prosurvival Bcl-2 family proteins, is a key step toward malignant transformation and therapeutic resistance. We report that depletion or acute inhibition of checkpoint kinase 1 (Chk1) is sufficient to restore γ-radiation-induced apoptosis in p53 mutant zebrafish embryos. Surprisingly, caspase-3 is not activated prior to DNA fragmentation, in contrast to classical intrinsic or extrinsic apoptosis. Rather, an alternative apoptotic program is engaged that cell autonomously requires atm (ataxia telangiectasia mutated), atr (ATM and Rad3-related) and caspase-2, and is not affected by p53 loss or overexpression of bcl-2/xl. Similarly, Chk1 inhibitor-treated human tumor cells hyperactivate ATM, ATR, and caspase-2 after γ-radiation and trigger a caspase-2-dependent apoptotic program that bypasses p53 deficiency and excess Bcl-2. The evolutionarily conserved "Chk1-suppressed" pathway defines a novel apoptotic process, whose responsiveness to Chk1 inhibitors and insensitivity to p53 and BCL2 alterations have important implications for cancer therapy.

AB - Evasion of DNA damage-induced cell death, via mutation of the p53 tumor suppressor or overexpression of prosurvival Bcl-2 family proteins, is a key step toward malignant transformation and therapeutic resistance. We report that depletion or acute inhibition of checkpoint kinase 1 (Chk1) is sufficient to restore γ-radiation-induced apoptosis in p53 mutant zebrafish embryos. Surprisingly, caspase-3 is not activated prior to DNA fragmentation, in contrast to classical intrinsic or extrinsic apoptosis. Rather, an alternative apoptotic program is engaged that cell autonomously requires atm (ataxia telangiectasia mutated), atr (ATM and Rad3-related) and caspase-2, and is not affected by p53 loss or overexpression of bcl-2/xl. Similarly, Chk1 inhibitor-treated human tumor cells hyperactivate ATM, ATR, and caspase-2 after γ-radiation and trigger a caspase-2-dependent apoptotic program that bypasses p53 deficiency and excess Bcl-2. The evolutionarily conserved "Chk1-suppressed" pathway defines a novel apoptotic process, whose responsiveness to Chk1 inhibitors and insensitivity to p53 and BCL2 alterations have important implications for cancer therapy.

KW - CELLBIO

KW - CELLCYCLE

KW - SIGNALING

UR - http://www.scopus.com/inward/record.url?scp=44149090307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44149090307&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2008.03.037

DO - 10.1016/j.cell.2008.03.037

M3 - Article

VL - 133

SP - 864

EP - 877

JO - Cell

JF - Cell

SN - 0092-8674

IS - 5

ER -